Concepedia

Sarah Calhoun

SC

Statistics

Publications

4

Citations

116

H-Index

4

Active since

2021

Affiliations

Rush University Medical Center(Current)

Northwestern University

Sarah Calhoun is an author at Rush University Medical Center specializing in cell biology, tumor biology, and cancer biology.

ORCID

Top concepts

Publications per year

2021–2022

4

Publications

4

Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells

Lei Duan, Sarah Calhoun, Daeun Shim et al. · Journal of Molecular Cell Biology · 2021 · 52 citations · Full text

, , +23

Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells

Sarah Calhoun, Lei Duan, Carl G. Maki · Translational Oncology · 2022 · 27 citations · Full text

RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

Lei Duan, Ricardo E. Perez, Sarah Calhoun et al. · Scientific Reports · 2022 · 20 citations · Full text

Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15

Lei Duan, Ricardo E. Perez, Sarah Calhoun et al. · Cancer Biology & Therapy · 2022 · 17 citations · Full text

, , +16

1–4 of 4